Resistencia antimicrobiana en infecciones genitourinarias: mecanismos, y nuevas estrategias terapéuticas

Jannet Jiménez Rodriguez

Authors

Jannet Jiménez Rodriguez Universidad Autónoma del Estado de Hidalgo, México. https://orcid.org/0009-0007-5207-7236

Keywords:

Urinary tract infections (UTIs), Antimicrobial resistance, Extended-spectrum β-lactamases, Horizontal gene transfer, Multidrug-resistant bacteria

Abstract

The rise of antibiotic-resistant infections is a critical public health issue, particularly due to the high prevalence of multidrug-resistant bacteria, which complicates treatment and places a significant burden on healthcare systems. This article aims to analyze the main mechanisms of antimicrobial resistance, such as the production of extended-spectrum β-lactamases, the activation of efflux pumps, and the modification of porins, which allow bacteria to evade the effects of antibiotics. In this context, urinary tract infections will be reviewed within the framework of resistance. Recent studies on antimicrobial resistance in bacteria causing genitourinary infections were collected, with a focus on current therapeutic strategies and emerging options. Existing strategies are discussed, highlighting the importance of rational antibiotic use, the implementation of rapid susceptibility testing, and the development of new alternatives, such as β-lactamase inhibitor combinations with β-lactam antibiotics and novel antimicrobials like plazomicin. Although these innovations offer new opportunities for treating resistant infections, preventing resistance requires control policies and epidemiological surveillance. In conclusion, to tackle antimicrobial resistance, it is crucial to implement responsible antibiotic use practices, strengthen rapid diagnostic strategies, and encourage research into innovative treatments.

Downloads

Download data is not yet available.

Publication Facts

This article

Author statements

Data availability

N/A

16%

External funding

No

32%

Competing interests

N/A

11%

This journal

Other journals

Articles accepted

70%

33%

Days to publication

90

145

Indexed in

DOAJ
GS

Editor & editorial board: profiles
Academic society: N/A
Publisher: Universidad Autónoma del Estado de Hidalgo

References

[1] Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex. Transm. Dis. 2019; 46(5): 304-11.

[2] Alós JI. Resistencia bacteriana a los antibióticos: una crisis global. Enferm. Infecc. Microbiol. Clin. 2015; 33(10): 692-9.

[3] Brauner A, Fridman O, Gefen O, Balaban NQ. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat. Rev. Microbiol. 2016; 14(5): 320-30.

[4] Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS. Antibiotic resistance and persistence-implications for human health and treatment perspectives. EMBO Rep. 2020; 21(12): e51034.

[5] Murray BO, Flores C, Williams C, Flusberg DA, Marr EE, Kwiatkowska KM, et al. Recurrent urinary tract infection: A mystery in search of better model systems. Front. Cell. Infect. Microbiol. 2021; 11: 691210.

[6] O'Shea SD, Pope R, Freire K, Orr R, Gallagher N. Genitourinary infections in Australian servicewomen. Neurourol. Urodyn. 2023; 42(8): 1668-75.

[7] National Human Genome Research Institute. Bacteria [Internet]. 2024 [cited 2025 Feb 17]. Available from: https://www.genome.gov/es/genetics-glossary/Bacteria

[8] Instituto Nacional del Cáncer. Infección urinaria [Internet]. Diccionario de cáncer. 2024 [cited 2025 Feb 17]. Available from: https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infeccion-urinaria

[9] Alós JI. Epidemiología y etiología de la infección urinaria comunitaria. Sensibilidad antimicrobiana de los principales patógenos y significado clínico de la resistencia. Enferm. Infecc. Microbiol. Clin. 2005; 23 (Suppl 1): 3-8.

[10] Ikäheimo R, Siitonen A, Heiskanen T, Kärkkäinen U, Kuosmanen P, Lipponen P, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin. Infect. Dis. 1996 Jan; 22(1): 91-9.

[11] Von Vietinghoff S, Shevchuk O, Dobrindt U, Engel DR, Jorch SK, Kurts C, et al. The global burden of antimicrobial resistance–urinary tract infections. Nephrol. Dial. Transplant. 2024; 39(4): 581-8.

[12] Artero-López J, Gutiérrez-Soto B, Expósito-Ruiz M, Sorlózano-Puerto A, Navarro-Marí JM, Gutiérrez-Fernández J. Etiología de las infecciones urinarias en nuestra área sanitaria y perfil de sensibilidad de los uropatógenos más frecuentes. Arch. Esp. Urol. 2021; 74(2): 97-207.

[13] López-Martínez B, Calderón-Jaimes E, Olivar-López V, Parra-Ortega I, Alcázar-López V, Castellanos-Cruz MDC, et al. Susceptibilidad antimicrobiana de microorganismos causantes de infección de vías urinarias bajas en un hospital pediátrico. Bol. Med. Hosp. Infant. Mex. 2014; 71(6): 339-45.

[14] Zare M, Vehreschild MJGT, Wagenlehner F. Management of uncomplicated recurrent urinary tract infections. BJU Int. 2022; 129(6): 668-78.

[15] Valdevenito SJP. Infección urinaria recurrente en la mujer. Rev. Chilena Infectol. 2008; 25(4): 268-76.

[16] Valdevenito JP, Álvarez D. Infección urinaria recurrente en la mujer. Rev. Méd. Clínica Las Condes. 2018; 29(2): 222-31.

[17] Rowe TA, Juthani-Mehta M. Urinary tract infection in older adults. Aging Health. 2013; 9(5): 10.2217/ahe.13.38.

[18] Karstens L, Asquith M, Caruso V, Rosenbaum JT, Fair DA, Braun J, et al. Community profiling of the urinary microbiota: considerations for low-biomass samples. Nat. Rev. Urol. 2018; 15(12): 735-49.

[19] Neugent ML, Hulyalkar NV, Nguyen VH, Zimmern PE, De Nisco NJ. Advances in understanding the human urinary microbiome and its potential role in urinary tract infection. mBio. 2020; 11(2): e00218-20.

[20] Jones J, Murphy CP, Sleator RD, Culligan EP. The urobiome, urinary tract infections, and the need for alternative therapeutics. Microb. Pathog. 2021; 161(Pt B): 105295.

[21] Moriyama B, Henning SA, Neuhauser MM, Danner RL, Walsh TJ. Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria. Ann. Pharmacother. 2009; 43(7): 1324-37.

[22] Goff D, Kullar R, Goldstein E, Gilchrist M, Nathwani D, Cheng A, et al. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect. Dis. 2017; 17(2): E56-63.

[23] Lepe JA, Martínez-Martínez L. Puesta al día en Medicina Intensiva: infecciones graves por gramnegativos multirresistentes. Mecanismos de resistencia en bacterias gramnegativas. Medicina Intensiva. 2022; 46(7): 392-402.

[24] Castro-Orozco R, Barreto-Maya AC, Guzmán-Álvarez H, Ortega-Quiroz RJ, Benítez-Peña L. Patrones de resistencia antimicrobiana en uropatógenos gramnegativos aislados de pacientes ambulatorios y hospitalizados Cartagena, 2005-2008. Rev. Salud Pública (Bogotá). 2010; 12(6): 1010-9.

[25] León-Luna D, Fajardo-Loyola A, Yareta-Yareta J, Burgos-Espejo A, Peralta-Siesquen C, Galarza-Pérez M, et al. Caracterización molecular de enterobacterias multirresistentes en dos departamentos de la selva peruana. Biomédica. 2021; 41(Sp. 2): 180-7.

[26] Guzmán M, Salazar E, Cordero V, Castro A, Villanueva A, Rodulfo H, et al. Multirresistencia a medicamentos y factores de riesgo asociados con infecciones urinarias por Escherichia coli adquiridas en la comunidad, Venezuela. Biomedica. 2019; 39(s1): 96-107.

[27] Džidić S, Šušković J, Kos B. Antibiotic resistance mechanisms in bacteria: Biochemical and genetic aspects. Food Technol. Biotechnol. 2008; 46(1): 11-21.

[28] Pulingam T, Parumasivam T, Mohd Gazzali A, Mohd Sulaiman A, Chee JY, Lakshmanan M, et al. Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur. J. Pharm. Sci. 2021; 170: 106103.

[29] Tao S, Chen H, Li N, Wang T, Liang W. The spread of antibiotic resistance genes in vivo model. Can. J. Infect. Dis. Med. Microbiol. 2022; 2022(1): 3348695.

[30] Aguinaga A, Gil-Setas A, Mazón Ramos A, Alvaro A, García-Irure JJ, Navascués A, et al. Infecciones del tracto urinario. Estudio de sensibilidad antimicrobiana en Navarra. An. Sist. Sanit. Navar. 2018; 41(1): 17-26.

[31] Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad. Med. 2020; 132(3): 234-50.